Aging WellEarly Phase 1NCT07731451
The Role of Brain Lactate Metabolism in Neuroprotection During Healthy Aging
A Early Phase 1 study testing Sodium lactate infusion and Exercise-induced hyperlactatemia in people with Aging Well and Aging, run by Northern Arizona University at 1 site in United States.
Trial summary
The brain's primary source of fuel is glucose. Unfortunately, the brain's ability to use glucose declines during normal aging. This decline in brain glucose metabolism makes it vulnerable to cognitive impairment and Alzheimer's disease. Read more about this study
- Who is it for?
- Ages 20 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Aging Well, Aging
- What is being tested?
- Sodium lactate infusion and Exercise-induced hyperlactatemia
- Type of treatment
- Injection or infusion
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteUnited States
- Study dates
- 1 Jan 2027to 1 Jan 2029
- Phase
- Early Phase 1
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Meet the American College of Sports Medicine (ACSM) physical activity guidelines for moderate-intensity aerobic activity, i.e., 150+ minutes of moderate or 75+ minutes of rigorous aerobic activity.
- The older cohort must have adhered to these physical activity guidelines for 30+ years.
- "Good" or "Excellent" aerobic fitness category based on ACSM standardized maximal aerobic power (V̇O2max) values for age and sex.
Who cannot join
- Need for daily medication for chronic conditions, diagnosed heart, lung, metabolic or cerebrovascular disease, smokers, pregnancy and women in perimenopause are exclusion criteria; these will be verified with questionnaires and preliminary screening.
- Significant carotid plaque will be excluded via ultrasound assessment.
- Evidence of mild cognitive impairment (MCI)
- Personal complaints of memory deficits, clinical diagnosis, or evidence from the NIH ToolBox ®V3 will be considered signs of MCI.
- Adverse responses to maximal exercise, or an inability to complete maximal exercise during fitness screening will also be exclusion criteria.
- known allergy to Lidocaine also cannot participate.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Northern Arizona University Dept of Biological Sciences
Flagstaff, Arizona, 86011
TRAVIS GIBBONS, PhD, 7785836976, travis.gibbons@nau.edu
About this study
Official title: Effects of Lactate on Brain Carbohydrate Metabolism in Healthy Aging
The brain's primary source of fuel is glucose. Unfortunately, the brain's ability to use glucose declines during normal aging. This decline in brain glucose metabolism makes it vulnerable to cognitive impairment and Alzheimer's disease. The brain can use another fuel source - lactate - which becomes available to the brain during exercise. The investigators have discovered that when lactate fuels the brain, brain glucose metabolism also improves. Essentially, from a metabolic angle, the brain appears younger. Recently, the investigators have shown that lactate - even in the absence of exercise - stimulates this beneficial effect on the brain. The investigators propose to compare the effects of lactate in healthy young and older adults to test whether these beneficial lactate-mediated effects persist throughout the lifespan, thereby providing a blueprint to restore youthful brain glucose metabolism.
Read the detailed description
The human brain has an immense energy demand that is fueled almost exclusively by glucose. Unfortunately, the brain's ability to metabolize glucose declines with age, and this is linked to neurodegenerative diseases. Finding ways to delay, halt, or reverse brain glucose hypo-metabolism is fundamental to promoting healthy brain aging. Exercise is a well-established way to improve brain glucose metabolism. The investigators have discovered a mechanism through exercise to selectively upregulate aerobic glycolysis - the specific pathway that is responsible for the age-related decline in whole brain glucose metabolism. Aerobic glycolysis is a unique form of glucose metabolism that does not undergo oxidative phosphorylation despite sufficient oxygen availability, and is essential during brain activation, learning, and memory formation, and is highest in the early stages of life when synaptic plasticity and growth are occurring at rapid rates. Preserving aerobic glycolysis during aging protects against Alzheimer's disease. The investigators have developed an experimental model that reproducibly upregulates aerobic glycolysis in a controlled manner using infusion of lactate - an alternative and preferred fuel for the brain. Whether lactate is increased passively via infusion, or actively via exercise, aerobic glycolysis is promoted, indicating that lactate may well be the key to activating brain aerobic glycolysis during exercise. The investigators objective is to exploit this unique role of lactate to evaluate changes in brain metabolism during healthy aging. The specific aims are to test whether aerobic glycolysis can be upregulated via lactate similarly in young and older healthy individuals and determine if age influences the neurotrophic and cognitive benefits afforded by lactate in young adults. The approach is to combine our invasive cross-brain blood sampling technique with stable isotope tracers to directly quantify brain substrate metabolism during exercise and lactate infusion in healthy young adults (aged 20-30) and healthy older adults (aged 65-80). This contribution is significant since aerobic glycolysis is a metabolic signature of a young, resilient brain. Identifying ways to naturally upregulate aerobic glycolysis throughout the lifespan will provide a framework to build therapies targeted toward healthy brain aging.
The general purpose is to characterize brain metabolism during healthy aging. The investigators will do this by directly assessing brain fuel metabolism in young and older humans in response to two interventions: 1) exercise, and 2) lactate infusion, both of which challenge the brain to use alternative fuels. It is hypothesized that: 1) when made available to the brain, lactate will spare glucose for aerobic glycolysis (a beneficial metabolic pathway) and stimulate the production of neurotrophic factors in the brain, and 2) that this metabolic 'flexibility' to upregulate aerobic glycolysis will be preserved in healthy aging. Generally, the investigators will test if this youthful pattern of aerobic glycolysis can be resurrected late in life through acute exercise. The specific aims are:
- Determine if increasing circulating lactate - passively via infusion and actively via exercise - translates to increased brain lactate metabolism equally in otherwise healthy young and elderly humans, i.e., brain is metabolic flexibility preserved across the lifespan?
- Verify that increasing brain lactate metabolism causes a proportional decrease in glucose oxidation, thus providing evidence for a glucose-sparing effect of lactate, and;
- Determine if lactate causes a similar neurotrophic and cognitive effect in healthy young and elderly humans, i.e., does exercise permit the same brain benefits throughout the lifespan?
- Conditions
- Aging Well, Aging
- Being tested
- Sodium lactate infusion, Exercise-induced hyperlactatemia
- Keywords
- brain metabolism, lactate, exercise, aging
- Medical subject headings
- Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Sodium lactate infusionBiological
Sodium lactate will be infused to target circulating concentrations between 4-6 mmol/L
Exercise-induced hyperlactatemiaOther
Cycling will be performed at an intensity to increase circulating lactate to 4-6 mmol/L
| Study group | Role | What they receive |
|---|---|---|
| Passive lactate | Active comparator | Circulating lactate will be elevated via infusion Receives: Biological: Sodium lactate infusion |
| Active lactate | Experimental | Circulating lactate will be elevated via exercise Receives: Other: Exercise-induced hyperlactatemia |
What is being measured
The primary outcome is the main question the study is designed to answer.
Cerebral metabolism
Lactate, glucose and oxygen metabolism via stable isotope tracers and Fick method using arterial and internal jugular venous blood sampling in combination with cerebral blood flow via ultrasound. These will be quantified as rates in grams/minute or mililiters/minute.
Measured: -Pre-intervention in rested state -During intervention when lactate is experimentally elevated -After recovery from intervention
Secondary outcomes (2)
Brain-specific biomarkers
Brain-derived neurotrophic factor, secreted amyloid-b precursor protein and platelet factor-4 will be quantified from concentrations measured in blood entering and exiting the brain via sampling from arterial and internal jugular venous blood.
Measured: -Pre-intervention in rested state -During intervention when lactate is experimentally elevated -After recovery from intervention
Cognitive function
Several domains of cognitive function will be assessed using NIH ToolBox V3.
Measured: -Pre-intervention in rested state -During intervention when lactate is experimentally elevated -After recovery from intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted28 Jul 2026
- Study start1 Jan 2027 (estimated)
- Primary completion1 Jan 2028 (estimated)
- Study completion1 Jan 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Aging WellStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Early Phase 1
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- Repeated measures cross-over
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Northern Arizona University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Travis Gibbons, Northern Arizona University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07731451
- Sponsor's protocol ID
- 2396277
- Status last verified
- Jul 2026
- First submitted
- 16 Jul 2026
- Last updated
- 28 Jul 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: To maintain privacy and confidentiality of participants.
Study at a glance
From the registry record, last updated by the sponsor on 28 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effects of Lactate on Brain Carbohydrate Metabolism in Healthy Aging
- ClinicalTrials.gov ID
- NCT07731451
- Acronym / sponsor ID
- 2396277
- Conditions
- Aging Well, Aging
- Keywords
- brain metabolism, lactate, exercise, aging
- Phase
- Early Phase 1
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Northern Arizona UniversityUniversity, hospital or other
- Study start
- 1 Jan 2027 (estimated)
- Primary completion
- 1 Jan 2028 (estimated)
- Study completion
- 1 Jan 2029 (estimated)
- First posted
- 28 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The brain's primary source of fuel is glucose. Unfortunately, the brain's ability to use glucose declines during normal aging. This decline in brain glucose metabolism makes it vulnerable to cognitive impairment and Alzheimer's disease. The brain can use another fuel source - lactate - which becomes available to the brain during exercise. The investigators have discovered that when lactate fuels the brain, brain glucose metabolism also improves. Essentially, from a metabolic angle, the brain appears younger. Recently, the investigators have shown that lactate - even in the absence of exercise - stimulates this beneficial effect on the brain. The investigators propose to compare the effects of lactate in healthy young and older adults to test whether these beneficial lactate-mediated effects persist throughout the lifespan, thereby providing a blueprint to restore youthful brain glucose metabolism.
Detailed description
The human brain has an immense energy demand that is fueled almost exclusively by glucose. Unfortunately, the brain's ability to metabolize glucose declines with age, and this is linked to neurodegenerative diseases. Finding ways to delay, halt, or reverse brain glucose hypo-metabolism is fundamental to promoting healthy brain aging. Exercise is a well-established way to improve brain glucose metabolism. The investigators have discovered a mechanism through exercise to selectively upregulate aerobic glycolysis - the specific pathway that is responsible for the age-related decline in whole brain glucose metabolism. Aerobic glycolysis is a unique form of glucose metabolism that does not undergo oxidative phosphorylation despite sufficient oxygen availability, and is essential during brain activation, learning, and memory formation, and is highest in the early stages of life when synaptic plasticity and growth are occurring at rapid rates. Preserving aerobic glycolysis during aging protects against Alzheimer's disease. The investigators have developed an experimental model that reproducibly upregulates aerobic glycolysis in a controlled manner using infusion of lactate - an alternative and preferred fuel for the brain. Whether lactate is increased passively via infusion, or actively via exercise, aerobic glycolysis is promoted, indicating that lactate may well be the key to activating brain aerobic glycolysis during exercise. The investigators objective is to exploit this unique role of lactate to evaluate changes in brain metabolism during healthy aging. The specific aims are to test whether aerobic glycolysis can be upregulated via lactate similarly in young and older healthy individuals and determine if age influences the neurotrophic and cognitive benefits afforded by lactate in young adults. The approach is to combine our invasive cross-brain blood sampling technique with stable isotope tracers to directly quantify brain substrate metabolism during exercise and lactate infusion in healthy young adults (aged 20-30) and healthy older adults (aged 65-80). This contribution is significant since aerobic glycolysis is a metabolic signature of a young, resilient brain. Identifying ways to naturally upregulate aerobic glycolysis throughout the lifespan will provide a framework to build therapies targeted toward healthy brain aging.
The general purpose is to characterize brain metabolism during healthy aging. The investigators will do this by directly assessing brain fuel metabolism in young and older humans in response to two interventions: 1) exercise, and 2) lactate infusion, both of which challenge the brain to use alternative fuels. It is hypothesized that: 1) when made available to the brain, lactate will spare glucose for aerobic glycolysis (a beneficial metabolic pathway) and stimulate the production of neurotrophic factors in the brain, and 2) that this metabolic 'flexibility' to upregulate aerobic glycolysis will be preserved in healthy aging. Generally, the investigators will test if this youthful pattern of aerobic glycolysis can be resurrected late in life through acute exercise. The specific aims are:
- Determine if increasing circulating lactate - passively via infusion and actively via exercise - translates to increased brain lactate metabolism equally in otherwise healthy young and elderly humans, i.e., brain is metabolic flexibility preserved across the lifespan?
- Verify that increasing brain lactate metabolism causes a proportional decrease in glucose oxidation, thus providing evidence for a glucose-sparing effect of lactate, and;
- Determine if lactate causes a similar neurotrophic and cognitive effect in healthy young and elderly humans, i.e., does exercise permit the same brain benefits throughout the lifespan?
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- Repeated measures cross-over
| Arm | Type | Receives |
|---|---|---|
| Passive lactate | Active comparator | Biological: Sodium lactate infusionCirculating lactate will be elevated via infusion |
| Active lactate | Experimental | Other: Exercise-induced hyperlactatemiaCirculating lactate will be elevated via exercise |
Who may qualify
- Ages
- 20 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Meet the American College of Sports Medicine (ACSM) physical activity guidelines for moderate-intensity aerobic activity, i.e., 150+ minutes of moderate or 75+ minutes of rigorous aerobic activity.
- The older cohort must have adhered to these physical activity guidelines for 30+ years.
- "Good" or "Excellent" aerobic fitness category based on ACSM standardized maximal aerobic power (V̇O2max) values for age and sex.
Key exclusion criteria (6 listed)
- Need for daily medication for chronic conditions, diagnosed heart, lung, metabolic or cerebrovascular disease, smokers, pregnancy and women in perimenopause are exclusion criteria; these will be verified with questionnaires and preliminary screening.
- Significant carotid plaque will be excluded via ultrasound assessment.
- Evidence of mild cognitive impairment (MCI)
- Personal complaints of memory deficits, clinical diagnosis, or evidence from the NIH ToolBox ®V3 will be considered signs of MCI.
- Adverse responses to maximal exercise, or an inability to complete maximal exercise during fitness screening will also be exclusion criteria.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Sodium lactate infusionSodium lactate will be infused to target circulating concentrations between 4-6 mmol/L | Biological | Passive lactate |
| Exercise-induced hyperlactatemiaCycling will be performed at an intensity to increase circulating lactate to 4-6 mmol/L | Other | Active lactate |
Primary outcome
Cerebral metabolism
Time frame: -Pre-intervention in rested state -During intervention when lactate is experimentally elevated -After recovery from intervention
Lactate, glucose and oxygen metabolism via stable isotope tracers and Fick method using arterial and internal jugular venous blood sampling in combination with cerebral blood flow via ultrasound. These will be quantified as rates in grams/minute or mililiters/minute.
2 secondary outcomes
Brain-specific biomarkers
Time frame: -Pre-intervention in rested state -During intervention when lactate is experimentally elevated -After recovery from intervention
Cognitive function
Time frame: -Pre-intervention in rested state -During intervention when lactate is experimentally elevated -After recovery from intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jul 2026.
- Individual participant dataSharing planned: No. To maintain privacy and confidentiality of participants.
Related trials for Aging Well
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Not yet recruiting
Lung Cancer and Aging: Improving Well-being for Older Adults With Lung Cancer
Lung Cancer
Recruiting
Study Evaluating the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults
Healthy Aging
Recruiting
Effects of Breathing Exercises on Cognition in Older Adults
Older Adults (65 Years and Older), Cognition
Not yet recruiting
Eccentric Exercise in Community-dwelling Older Adults
Ageing Well
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Early Phase 1 study testing Sodium lactate infusion and Exercise-induced hyperlactatemia in people with Aging Well and Aging, run by Northern Arizona University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 28 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact TRAVIS GIBBONS, PhD (17785836976, travis.gibbons@nau.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Cerebral metabolism (time frame: -Pre-intervention in rested state -During intervention when lactate is experimentally elevated -After recovery from intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2026.